SmallCaps
ASX:GTGPharmaceuticals, Biotechnology & Life SciencesLife Sciences Tools & Services

Genetic Technologies Ltd

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company.

$0.039 $0.000 (0.00%)AUD · Suspended
Day Range
$0.039$0.039
52 Week Range
$0.000$0.039
Volume
0.00
Avg Volume (10D)
0.00
Market Cap
$52.08M
The company

The business

What Genetic Technologies Ltd does

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. It offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company's segments include EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment relates to EasyDNA branded test sales and expenses. The AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType/Corporate: relates to geneType branded test sales and expense, includes corporate charges.

Incorporated
AUS
Public since
1987-07-30
Employees
58
Shareholders
4,528
Advertisement

Small Caps Research

Independent ASX small-cap coverage

No research on Genetic Technologies Ltd yet

We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise GTG based on demand.

Share price & key data

Share price

OHLC · volume · moving averages
$0.039+$0.000 (+0.00%)over 6M
Hi$0.039Lo$0.000
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today
Open
$0.039
Prev Close
$0.039
Day High
$0.039
Day Low
$0.039
52wk High
$0.039
52wk Low
$0.000

Valuation

Multiples
Market Cap
$52.08M
Shares Out
1.34B

Trading Activity

Volume & book
Volume
0.00
Value Traded
$0.00
Avg Vol 10D
0.00
Peers & news

Looking for charts & signals? See the tab.

◆ FREE MEMBER ACCESS

Unlock the full research library - free.

Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.

Full broker research library
Complete CEO interview archive
IPO calendar and alerts
New research alerts
Mobile notifications
Members-only market wraps
◆ Free account
Start free
No credit card · Takes 30 seconds · 200,000+ members
Unlock free access →
Continue with Google or email through our secure Auth0 signup.